Skip navigation

Health Care News and Ideas for Medical Conference Organizers

INDUSTRY NOTES A biotech startup will team up with Merck to educate physicians about HIV drug-resistance testing. ViroLogic Inc. and Merck & Co. Inc. will jointly develop and execute educational programs on the utility of HIV drug-resistance testing for physicians across the nation. ViroLogic is a South San Francisco, Calif.-based biotechnology company specializing in developing treatments for serious viral, immunologic, and oncologic diseases.

Register to view the full article

Register for MeetingsNet.com and gain access to premium content including the CMI 25 Listing, our monthly digital edition, the MeetingsNet app, live and on-demand webinars, and much more.

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish